Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate 7-day monotherapy for uncomplicated falciparum malaria in Guyana
ACTRN12616000526471Phase 4Completed
- Sponsor
- World Health Organization
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artesunate in Malaria, sponsored by World Health Organization. Primary endpoints: Treatment outcome at day 28, Day 3 positivity rate and 2 more. Started Jun 2014; status: completed.
02
Drugs
artesunate
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12616000526471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000526471.